His research is interdisciplinary, bridging the disciplines of Metabolite profiling and Metabolomics. In most of his Bioinformatics studies, his work intersects topics such as Lipidomics. His study brings together the fields of Bioinformatics and Lipidomics. In his works, Thomas O. Metz undertakes multidisciplinary study on Metagenomics and Metaproteomics. He integrates many fields, such as Metaproteomics and Metagenomics, in his works. While working on this project, he studies both Gene and Function (biology). Thomas O. Metz regularly ties together related areas like Genetics in his Function (biology) studies. He integrates several fields in his works, including Genetics and Evolutionary biology. Thomas O. Metz incorporates Evolutionary biology and Gene in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez.
Nature Biotechnology (2016)
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Gil Sharon;Nikki Jamie Cruz;Dae Wook Kang;Michael J. Gandal.
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics.
Deborah L. Diamond;Andrew J. Syder;Jon M. Jacobs;Christina M. Sorensen.
PLOS Pathogens (2010)
A Perspective on the Maillard Reaction and the Analysis of Protein Glycation by Mass Spectrometry: Probing the Pathogenesis of Chronic Disease
Qibin Zhang;Jennifer M. Ames;Richard D. Smith;John W. Baynes.
Journal of Proteome Research (2009)
Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells.
Rushika Perera;Catherine Riley;Giorgis Isaac;Amber S. Hopf-Jannasch.
PLOS Pathogens (2012)
Automated 20 kpsi RPLC-MS and MS/MS with Chromatographic Peak Capacities of 1000−1500 and Capabilities in Proteomics and Metabolomics
Yufeng Shen;Rui Zhang;Ronald J. Moore;Jeongkwon Kim.
Analytical Chemistry (2005)
A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation
Paul A. Voziyan;Thomas O. Metz;John W. Baynes;Billy G. Hudson.
Journal of Biological Chemistry (2002)
Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Thomas O Metz;Nathan L Alderson;Suzanne R Thorpe;John W Baynes.
Archives of Biochemistry and Biophysics (2003)
Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
Vineet D. Menachery;Amie J. Eisfeld;Alexandra Schäfer;Laurence Josset.
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Lisa E. Gralinski;Armand Bankhead;Sophia Jeng;Vineet D. Menachery.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: